Opdivo® (nivolumab) Approved as Adjuvant Treatment for Eligible Patients with Completely Resected Stage IIB or Stage IIC Melanoma
…in Patients with Resected Early-Stage Melanoma. Dermatol Ther (Heidelb). 2020;10(5):985-999. doi:10.1007/s13555-020-00404-9 What Is Melanoma Skin Cancer? American Cancer Society. https://www.cancer.org/cancer/melanoma-skin-cancer/about/what-is-melanoma.html.…















